about
Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors.Second-generation kinase inhibitors.Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Src inhibitors: genomics to therapeutics.
@ast
Src inhibitors: genomics to therapeutics.
@en
Src inhibitors: genomics to therapeutics.
@nl
type
label
Src inhibitors: genomics to therapeutics.
@ast
Src inhibitors: genomics to therapeutics.
@en
Src inhibitors: genomics to therapeutics.
@nl
prefLabel
Src inhibitors: genomics to therapeutics.
@ast
Src inhibitors: genomics to therapeutics.
@en
Src inhibitors: genomics to therapeutics.
@nl
P2093
P2860
P1476
Src inhibitors: genomics to therapeutics.
@en
P2093
P2860
P304
P356
10.1517/13543784.10.7.1327
P407
P577
2001-07-01T00:00:00Z